{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:10:00Z","timestamp":1765825800532,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ajpath.2020.04.001","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T01:50:52Z","timestamp":1587001852000},"page":"1172-1174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Podocytes"],"prefix":"10.1016","volume":"190","author":[{"given":"Marica","family":"Giliberti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Mitrotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2020.04.001_bib1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.ki.5002222","article-title":"The spectrum of podocytopathies: a unifying view of glomerular diseases","volume":"71","author":"Wiggins","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2020.04.001_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1053\/j.ajkd.2019.01.033","article-title":"Genetics of nephrotic syndrome presenting in childhood: core curriculum 2019","volume":"74","author":"Watanabe","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajpath.2020.04.001_bib3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/j.ajkd.2011.05.032","article-title":"Podocyte disorders: core curriculum 2011","volume":"58","author":"Jefferson","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajpath.2020.04.001_bib4","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/ijms21051559","article-title":"Podocyte lysosome dysfunction in chronic glomerular diseases","volume":"21","author":"Li","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2020.04.001_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00020.2002","article-title":"Cell biology of the glomerular podocyte","volume":"83","author":"Pavenst\u00e4dt","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajpath.2020.04.001_bib6","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.bbamem.2006.08.019","article-title":"Acid ceramidase and human disease","volume":"1758","author":"Park","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2020.04.001_bib7","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.178.4065.1100","article-title":"Ceramidase deficiency in Farber's disease (lipogranulomatosis)","volume":"178","author":"Sugita","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2020.04.001_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2012.05.001","article-title":"Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1","volume":"91","author":"Zhou","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpath.2020.04.001_bib9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ajpath.2020.02.008","article-title":"Podocytopathy and nephrotic syndrome in mice with podocyte-specific deletion of the Asah1 gene: role of ceramide accumulation in glomeruli","volume":"190","author":"Li","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2020.04.001_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mds.27895","article-title":"The vicious cycle between \u03b1-synuclein aggregation and autophagic-lysosomal dysfunction","volume":"35","author":"Bellomo","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.ajpath.2020.04.001_bib11","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/S0021-9258(18)51879-2","article-title":"Enzymic hydrolysis and synthesis of ceramides","volume":"238","author":"Gatt","year":"1963","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2020.04.001_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.critrevonc.2019.03.018","article-title":"Sphingolipids and acid ceramidase as therapeutic targets in cancer therapy","volume":"138","author":"Govindarajah","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ajpath.2020.04.001_bib13","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2217\/fon.10.116","article-title":"Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance","volume":"6","author":"Ponnusamy","year":"2010","journal-title":"Future Oncol"},{"key":"10.1016\/j.ajpath.2020.04.001_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2020.04.001_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejca.2015.10.056","article-title":"Targeting acid ceramidase sensitises head and neck cancer to cisplatin","volume":"52","author":"Roh","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2020.04.001_bib16","doi-asserted-by":"crossref","first-page":"7411","DOI":"10.1038\/s41598-017-07606-w","article-title":"Complete acid ceramidase ablation prevents cancer-initiating cell formation in melanoma cells","volume":"7","author":"Lai","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2020.04.001_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/PGP.0b013e3182673982","article-title":"Acid ceramidase (AC)\u2013a key enzyme of sphingolipid metabolism\u2013correlates with better prognosis in epithelial ovarian cancer","volume":"32","author":"Hanker","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajpath.2020.04.001_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13023-018-0845-z","article-title":"Acid ceramidase deficiency: farber disease and SMA-PME","volume":"13","author":"Yu","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ajpath.2020.04.001_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cmet.2012.04.002","article-title":"Ceramide-centric view of insulin resistance","volume":"15","author":"Chavez","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpath.2020.04.001_bib20","doi-asserted-by":"crossref","first-page":"20296","DOI":"10.1074\/jbc.274.29.20296","article-title":"Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A","volume":"274","author":"Ruvolo","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2020.04.001_bib21","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.ki.5001834","article-title":"Lipotoxicity","volume":"70","author":"Weinberg","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2020.04.001_bib22","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.biochi.2013.07.017","article-title":"Ectopic lipid accumulation: a potential cause for metabolic disturbances and a contributor to the alteration of kidney function","volume":"95","author":"Guebre-Egziabher","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.ajpath.2020.04.001_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.metabol.2018.02.004","article-title":"Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy","volume":"85","author":"Choi","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.ajpath.2020.04.001_bib24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1681\/ASN.2019050497","article-title":"Accumulation of globotriaosylceramide in podocytes in fabry nephropathy is associated with progressive podocyte loss","volume":"31","author":"Najafian","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajpath.2020.04.001_bib25","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944020301966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944020301966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:36:30Z","timestamp":1757694990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944020301966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0002944020301966"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2020.04.001","relation":{},"ISSN":["0002-9440"],"issn-type":[{"type":"print","value":"0002-9440"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Podocytes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2020.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2020.02.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}